Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Methodology
Signal backtests
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Hari Parameswaran — Obsidian Therapeutics, Inc. insider · InsiderLens

Pricing Sign in

/ / Hari Parameswaran

Hari Parameswaran

Chief Medical Officer at Obsidian Therapeutics, Inc. · on record since Aug 3, 2026

Insider trading activity of Hari Parameswaran

No transactions on record for Hari Parameswaran.

Track record of Hari Parameswaran

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hari Parameswaran

Co-insiders of Hari Parameswaran

Barrett PeterObsidian Therapeutics, Inc.
Fardis MariaObsidian Therapeutics, Inc.
Feder Julie BObsidian Therapeutics, Inc.
Hagen HeidiObsidian Therapeutics, Inc.
Jagasia MadanObsidian Therapeutics, Inc.
Norkunas MatthewObsidian Therapeutics, Inc.
ROSS ROBERT W.Obsidian Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters